01
What they do
VoxCell develops vascularized, 3D-bioprinted human tissue models for preclinical research. Its models incorporate channels lined with endothelial cells, allowing researchers to investigate how compounds interact with tissue and its vascular features. Initial applications include breast and lung cancer research.
RocketBio holds a board seat and supports business development.
Selected collaborations
Novel therapeutic. Commenced 2026.

Radiation, with the University of Victoria. Commenced 2025.
Commenced 2025.



